# FDA 483 - CellTrans Inc. - June 11, 2021

Source: https://www.globalkeysolutions.net/records/483/celltrans-inc/eabc837b-2080-42d9-8ede-acc82db8982e

> FDA 483 for CellTrans Inc. on June 11, 2021. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: CellTrans Inc.
- Inspection Date: 2021-06-11
- Product Type: biologics
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Officers

- [Gena Arcy, CSO](https://www.globalkeysolutions.net/people/gena-arcy-cso/5e73742f-22df-4750-82a8-430f86192916)
- [Prajakta A. Varadkar](https://www.globalkeysolutions.net/people/prajakta-a-varadkar/93c01972-2e91-462e-8c2b-4a6520d3dd3f)
- [Pankaj Amin, CSO](https://www.globalkeysolutions.net/people/pankaj-amin-cso/d01a4c72-08cd-409e-99bc-3e54afcbd17a)

Company: https://www.globalkeysolutions.net/companies/celltrans-inc/f107fb49-e519-4286-880e-2374e9ffa149

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd